Drugs / Pliaglis
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | PLIAGLIS | — | 2006-06-29 | fda.gov ↗ |
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01951820 | Aug 2013 → Jun 2014 | — | University of Michigan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pliaglis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01951820 ↗ |
| Route | Topical | “Apply 0.2mg of compounded topical anesthetic (Pliaglis) to gums” NCT01951820 ↗ |